Rentokil Initial PLC Director/PDMR Shareholding

RNS Number : 0220Q

Rentokil Initial PLC

13 December 2024

 

Rentokil Initial plc (the "Company")

13 December 2024

 

Notification of a transaction by a Person Closely Associated ('PCA') with a Person Discharging Managerial Responsibility ('PDMR')

 

The Company hereby announces that Trian Fund Management, L.P., a PCA of Brian Baldwin (a Non-Executive Director of the Company), has purchased 7,500,000 ordinary shares in the Company at a price of 413.4137 pence per share on 11 December 2024.

 

The relevant notification set out below is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

 

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Trian Fund Management, L.P.
2	Reason for the notification
a)	Position/status	Person Closely Associated with a Person Discharging Managerial Responsibilities (Brian Baldwin, Non-Executive Director)
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Rentokil Initial plc
b)	LEI	549300VN4WV7Z6T14K68
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument   Identification code	Ordinary shares of 1p each     ISIN: GB00B082RF11
b)	Nature of the transaction	Purchase of shares by certain funds managed by Trian Fund Management, L.P.
c)	Price(s) and volume(s)	Price(s)   Volume(s) £4.134137 (weighted average) 7,500,000
d)	Aggregated information   - Aggregated volume   - Total price	7,500,000   £31,006,028
e)	Date of the transaction	2024-12-11
f)	Place of the transaction	London Stock Exchange (XLON)

 

Enquiries:

Rachel Canham, Group General Counsel & Company Secretary  

Tel: [phone]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

DSHGRBDDLGBDGSX